152 related articles for article (PubMed ID: 27486205)
21. Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease.
Tanabe N; Muro S; Tanaka S; Sato S; Oguma T; Kiyokawa H; Takahashi T; Kinose D; Hoshino Y; Kubo T; Ogawa E; Hirai T; Mishima M
Respir Res; 2012 Apr; 13(1):31. PubMed ID: 22512922
[TBL] [Abstract][Full Text] [Related]
22. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P; Celli B; Agustí A; Boje Jensen G; Divo M; Faner R; Guerra S; Marott JL; Martinez FD; Martinez-Camblor P; Meek P; Owen CA; Petersen H; Pinto-Plata V; Schnohr P; Sood A; Soriano JB; Tesfaigzi Y; Vestbo J
N Engl J Med; 2015 Jul; 373(2):111-22. PubMed ID: 26154786
[TBL] [Abstract][Full Text] [Related]
23. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
Wise RA
Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
[TBL] [Abstract][Full Text] [Related]
24. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
[TBL] [Abstract][Full Text] [Related]
25. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
Halper-Stromberg E; Yun JH; Parker MM; Singer RT; Gaggar A; Silverman EK; Leach S; Bowler RP; Castaldi PJ
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):500-509. PubMed ID: 29206476
[TBL] [Abstract][Full Text] [Related]
26. Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
Bhatt SP; Soler X; Wang X; Murray S; Anzueto AR; Beaty TH; Boriek AM; Casaburi R; Criner GJ; Diaz AA; Dransfield MT; Curran-Everett D; Galbán CJ; Hoffman EA; Hogg JC; Kazerooni EA; Kim V; Kinney GL; Lagstein A; Lynch DA; Make BJ; Martinez FJ; Ramsdell JW; Reddy R; Ross BD; Rossiter HB; Steiner RM; Strand MJ; van Beek EJ; Wan ES; Washko GR; Wells JM; Wendt CH; Wise RA; Silverman EK; Crapo JD; Bowler RP; Han MK;
Am J Respir Crit Care Med; 2016 Jul; 194(2):178-84. PubMed ID: 26808615
[TBL] [Abstract][Full Text] [Related]
27. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
28. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
29. Annual change in FEV
Suzuki M; Makita H; Konno S; Shimizu K; Nasuhara Y; Nagai K; Akiyama Y; Fuke S; Saito H; Igarashi T; Takeyabu K; Nishimura M
Sci Rep; 2019 Feb; 9(1):2073. PubMed ID: 30765818
[TBL] [Abstract][Full Text] [Related]
30. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
Zhou Y; Zhong NS; Li X; Chen S; Zheng J; Zhao D; Yao W; Zhi R; Wei L; He B; Zhang X; Yang C; Li Y; Li F; Du J; Gui J; Hu B; Bai C; Huang P; Chen G; Xu Y; Wang C; Liang B; Li Y; Hu G; Tan H; Ye X; Ma X; Chen Y; Hu X; Tian J; Zhu X; Shi Z; Du X; Li M; Liu S; Yu R; Zhao J; Ma Q; Xie C; Li X; Chen T; Lin Y; Zeng L; Ye C; Ye W; Luo X; Zeng L; Yu S; Guan WJ; Ran P
N Engl J Med; 2017 Sep; 377(10):923-935. PubMed ID: 28877027
[TBL] [Abstract][Full Text] [Related]
31. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease.
Harber P; Tashkin DP; Simmons M; Crawford L; Hnizdo E; Connett J;
Am J Respir Crit Care Med; 2007 Nov; 176(10):994-1000. PubMed ID: 17626912
[TBL] [Abstract][Full Text] [Related]
32. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
Smith BM; Kirby M; Hoffman EA; Kronmal RA; Aaron SD; Allen NB; Bertoni A; Coxson HO; Cooper C; Couper DJ; Criner G; Dransfield MT; Han MK; Hansel NN; Jacobs DR; Kaufman JD; Lin CL; Manichaikul A; Martinez FJ; Michos ED; Oelsner EC; Paine R; Watson KE; Benedetti A; Tan WC; Bourbeau J; Woodruff PG; Barr RG;
JAMA; 2020 Jun; 323(22):2268-2280. PubMed ID: 32515814
[TBL] [Abstract][Full Text] [Related]
33. Effects of Systematic Intervention for Chronic Obstructive Pulmonary Disease on Follow-up and Smoking Cessation Rates and Changes of the Pulmonary Function: A 7-year Longitudinal Study in a Japanese Rural City.
Tanaka K; Senjyu H; Tawara Y; Tanaka T; Asai M; Tabusadani M; Honda S; Sawai T; Kozu R
Intern Med; 2018 Aug; 57(16):2315-2323. PubMed ID: 29526966
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD.
Johnson KM; Safari A; Tan WC; Bourbeau J; FitzGerald JM; Sadatsafavi M; Study OBOTCCOOLDC;
Int J Chron Obstruct Pulmon Dis; 2018; 13():3983-3995. PubMed ID: 30587954
[TBL] [Abstract][Full Text] [Related]
35. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Gan WQ; Man SF; Postma DS; Camp P; Sin DD
Respir Res; 2006 Mar; 7(1):52. PubMed ID: 16571126
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal changes in lung hyperinflation in COPD.
Park J; Lee CH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
Int J Chron Obstruct Pulmon Dis; 2017; 12():501-508. PubMed ID: 28223790
[TBL] [Abstract][Full Text] [Related]
37. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.
Tashkin DP; Rabinoff M; Noble EP; Ritchie TL; Simmons MS; Connett J
COPD; 2012 Dec; 9(6):620-8. PubMed ID: 22958175
[TBL] [Abstract][Full Text] [Related]
38. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
39. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.
Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A
Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842
[No Abstract] [Full Text] [Related]
40. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
